According to Regeneron Pharmaceuticals's latest financial reports and stock price the company's current number of shares outstanding is 107,100,000. At the end of 2023 the company had 107,100,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.10 B | 0.09% |
2022 | 0.10 B | 0.75% |
2021 | 0.10 B | 0.76% |
2020 | 0.10 B | -3.48% |
2019 | 0.10 B | 0.92% |
2018 | 0.10 B | 1.1% |
2017 | 0.10 B | 1.82% |
2016 | 0.10 B | 1.3% |
2015 | 0.10 B | 2.26% |
2014 | 0.10 B | 2.63% |
2013 | 98.86 M | 3.31% |
2012 | 95.69 M | 5.1% |
2011 | 91.04 M | 4.17% |
2010 | 87.4 M | 9.44% |
2009 | 79.86 M | 1.18% |
2008 | 78.93 M | 19.48% |
2007 | 66.06 M | 15.89% |
2006 | 57.01 M | 1.85% |
2005 | 55.97 M | 0.92% |
2004 | 55.46 M | 5.27% |
2003 | 52.69 M | 19.89% |
2002 | 43.95 M | 1.43% |
2001 | 43.32 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | 2,598,734,075 | 2,326.46% | ๐บ๐ธ USA |
![]() Novartis NVS | 2,083,000,000 | 1,844.91% | ๐จ๐ญ Switzerland |
![]() Amgen AMGN | 534,000,000 | 398.60% | ๐บ๐ธ USA |
![]() Sanofi SNY | 2,498,600,000 | 2,232.96% | ๐ซ๐ท France |
![]() Biogen BIIB | 144,400,000 | 34.83% | ๐บ๐ธ USA |
![]() Alnylam Pharmaceuticals
ALNY | 124,111,000 | 15.88% | ๐บ๐ธ USA |